ArticleMolecular plant pathology2026
DrdR Negatively Modulates the Expression of Flagellar Genes via Interaction With FleQ in Xanthomonas campestris.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Response regulators (RRs) of two-component signalling systems (TCSs) containing tandem receiver (REC) domains are widespread in bacteria, yet their functions and regulatory mechanisms remain poorly understood. In our previous study, DrdR, one such RR in the cruciferous black rot disease pathogen Xanthomonas campestris pv. campestris (Xcc) was demonstrated to positively regulate pilus-dependent motility and negatively regulate flagellum-dependent motility. We showed that DrdR modulates the ATPase activities of pili motor proteins PilT and PilB, thereby enhancing bacterial pilus-dependent swarming motility. However, how DrdR represses flagellar motility remained unknown. Here, we demonstrate that DrdR acts as a transcriptional repressor of flagellar gene expression. We used in vitro and in vivo approaches to identify FleQ, the master transcriptional regulator of flagellar genes, as a novel interaction partner of DrdR. Biochemical analyses revealed that DrdR binding inhibits FleQ's ATPase activity, which is essential for its transcriptional activation function. Microscale thermophoresis assays showed that DrdR reduces FleQ's DNA-binding capability to its cognate promoter. These findings collectively indicate that DrdR modulates FleQ transcriptional activity by reducing both its DNA-binding ability and ATPase activity. Our results demonstrate that DrdR serves as a specialized modulator of FleQ that acts upstream in the signalling cascade controlling the expression of flagellar genes in Xcc. This study exhibits a previously unknown mechanism whereby DrdR regulates bacterial motility. Combined with our previous finding, our data suggest that DrdR most likely acts as a conversion regulator between flagellum-dependent and pilus-dependent motility in Xcc.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.